AbbVie Other Non-Current Liabilities 2010-2024 | ABBV

AbbVie other non-current liabilities for the quarter ending September 30, 2024 were $33.031B, a 4.38% increase year-over-year.

  • AbbVie other non-current liabilities for 2023 were $32.327B, a 5.45% increase from 2022.
  • AbbVie other non-current liabilities for 2022 were $30.655B, a 6.81% increase from 2021.
  • AbbVie other non-current liabilities for 2021 were $28.701B, a 3.96% increase from 2020.

AbbVie Other Non-Current Liabilities 2010-2024 | ABBV

  • AbbVie other non-current liabilities for 2023 were $32.327B, a 5.45% increase from 2022.
  • AbbVie other non-current liabilities for 2022 were $30.655B, a 6.81% increase from 2021.
  • AbbVie other non-current liabilities for 2021 were $28.701B, a 3.96% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B